Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

211 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The elevated pre-operative plasma fibrinogen level is an independent negative prognostic factor for cancer-specific, disease-free and overall survival in soft-tissue sarcoma patients.
Szkandera J, Pichler M, Liegl-Atzwanger B, Absenger G, Stotz M, Ploner F, Stojakovic T, Samonigg H, Eberhard K, Leithner A, Gerger A. Szkandera J, et al. Among authors: samonigg h. J Surg Oncol. 2014 Feb;109(2):139-44. doi: 10.1002/jso.23458. J Surg Oncol. 2014. PMID: 24122271
Pre-treatment anemia is a poor prognostic factor in soft tissue sarcoma patients.
Szkandera J, Gerger A, Liegl-Atzwanger B, Stotz M, Samonigg H, Ploner F, Stojakovic T, Leithner A, Pichler M. Szkandera J, et al. Among authors: samonigg h. PLoS One. 2014 Sep 10;9(9):e107297. doi: 10.1371/journal.pone.0107297. eCollection 2014. PLoS One. 2014. PMID: 25207808 Free PMC article.
The ethics of space, design and color in an oncology ward.
Andritsch E, Stöger H, Bauernhofer T, Andritsch H, Kasparek AK, Schaberl-Moser R, Ploner F, Samonigg H. Andritsch E, et al. Among authors: samonigg h. Palliat Support Care. 2013 Jun;11(3):215-21. doi: 10.1017/S1478951512000077. Epub 2012 Aug 10. Palliat Support Care. 2013. PMID: 22883931
A phase I/II study of 4'-O-tetrahydropyranyl-doxorubicin, 5-fluorouracil, and high-dose leucovorin as first-line therapy in advanced breast cancer patients.
Stöger H, Bauernhofer T, Schmid M, Ploner F, Moser R, Derstvenscheg E, Steindorfer P, Wilders-Truschnig M, Kuss I, Samonigg H. Stöger H, et al. Among authors: samonigg h. Cancer Chemother Pharmacol. 1994;35(2):174-8. doi: 10.1007/BF00686643. Cancer Chemother Pharmacol. 1994. PMID: 7987997 Clinical Trial.
211 results